Article
08 Apr 2026
Executive Order Imposing Section 232 Tariffs On Pharmaceuticals And Pharmaceutical Ingredients
AUTHORS CONTENT
Article
11 Mar 2026
CMS ACCESS Model: Payments Announced Ahead Of April 1 Application Deadline
Article
25 Feb 2026
Healthcare Sector Pushes For H-1B Exemptions
Article
14 Jan 2026
CMS LEAD Model Cracks Door Open To Cannabis Conversation
Article
11 Dec 2025
CMS Announces ACCESS (Advancing Chronic Care With Effective, Scalable Solutions) Model
Article
24 Nov 2025
FDA Leadership Outlines "Plausible Mechanism" Pathway For Bespoke Therapies
Article
24 Sep 2025
Healthcare Companies Must Act Quickly After CMS Launches $50 Billion Rural Health Transformation Program
Article
20 Aug 2025
Can New State Licensing Pathways For Foreign Medical Graduates Reshape Physician Staffing And Recruitment Landscape?
Article
12 Mar 2025
Year In Preview: Review Of And Insights Into Investigations By The 119th Congress
Article
21 Nov 2024
BIOSECURE Act: Industry Closely Following In The Lame Duck
Article
12 Nov 2024
What President-Elect Trump's Victory Means For Healthcare In 2025
Article
12 Apr 2024
Healthcare Issues To Watch Following The FY2024 Spending Deal
Article
08 Feb 2024
Increased PFAS Reporting, Potential For Congressional Action Looms Over Industry In 2024
Article
04 Jan 2024
Department Of State Announces Domestic Visa Renewal Pilot For Certain H-1B Visa Applicants
Article
27 Nov 2023
OMB Releases Artificial Intelligence Memorandum To Federal Agencies
Article
03 Nov 2023
President Biden Issues Executive Order On Use Of Artificial Intelligence In Healthcare Settings
Article
17 Aug 2023
CMS Proposes Updates To Medicare Dental Coverage Pathway
Article
03 Aug 2023
Big Four Health Committee Leaders Release Request For Information On Regulation Of Cannabidiol
Article
13 Apr 2023
Bills Reintroduced In Congress After FDA Signals Potential New Regulatory Pathway For Cannabidiol Products
Article
10 Dec 2021
Review Of COVID-19 Testing Guidance For Travelers To The U.S.